How has been the historical performance of Shilpa Medicare?
Shilpa Medicare has demonstrated a generally upward trend in net sales and profits, with net sales increasing from 1,050.11 Cr in Mar'23 to 1,286.41 Cr in Mar'25, and profit before tax recovering to 123.60 Cr in Mar'25 from a loss in the previous year. The company's earnings per share improved significantly from -3.74 to 8.01 during the same period, indicating strong financial recovery.
Answer:The historical performance of Shilpa Medicare shows a fluctuating yet generally upward trend in net sales and profits over the years, with significant improvements noted in the most recent fiscal year.Breakdown:
Shilpa Medicare's net sales increased from 1,050.11 Cr in Mar'23 to 1,286.41 Cr in Mar'25, reflecting a strong growth trajectory. The total operating income followed a similar pattern, rising from 1,050.11 Cr in Mar'23 to 1,286.41 Cr in Mar'25. The company's operating profit (PBDIT) also saw a notable increase, climbing from 119.68 Cr in Mar'23 to 340.20 Cr in Mar'25, indicating improved operational efficiency. Profit before tax turned positive at 123.60 Cr in Mar'25, recovering from a loss of -34.47 Cr in Mar'23, while profit after tax rose to 79.57 Cr from a loss of -27.11 Cr in the previous year. The earnings per share (EPS) improved significantly from -3.74 in Mar'23 to 8.01 in Mar'25. On the balance sheet, total assets increased from 2,903.93 Cr in Mar'23 to 3,297.74 Cr in Mar'25, while total liabilities rose from 2,903.93 Cr to 3,297.74 Cr over the same period. The cash flow from operating activities remained relatively stable, with a slight decrease from 136.00 Cr in Mar'24 to 132.00 Cr in Mar'25. Overall, Shilpa Medicare's financial performance has shown resilience and recovery, particularly in the last fiscal year.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
